The Delivery of "Doing What Matters in Times of Stress: An Illustrated Guide"

Sponsor
Koç University (Other)
Overall Status
Completed
CT.gov ID
NCT04631887
Collaborator
(none)
126
1
2
2.7
47.3

Study Details

Study Description

Brief Summary

The feasibility study for the delivery of the "Doing What Matters in Times of Stress: An Illustrated Guide" will be carried out for Turkish and Syrian individuals with psychological stress. This feasibility study's sample will be adult Turkish and the Syrian refugees. The informed consent form and screening questionnaire of the feasibility study will be sent to the participants who have given this approval and 128 (64 Turkish and 64 Syrian) participants who meet the inclusion criteria will be included in the feasibility study. The psychological problems will be measured twice, before and after the intervention.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Doing What Matters in Times of Stress: An Illustrated Guide
N/A

Detailed Description

Studies about the impact of epidemics such as Severe acute respiratory syndrome (SARS) on the psychological health of individuals show that psychological problems have been observed in individuals who are affected by the epidemic. Today, studies on the effects of COVID-19 on psychological health are also available in the literature, and the results of these studies are in line with those of previous studies on epidemics.

The aim of this project is to deliver the "Doing What Matters in Times of Stress: An Illustrated Guide" that is developed by the World Health Organization within Self Help Plus (SH+) intervention to decrease their psychological problems for a feasibility study. The feasibility study for the delivery of the SH+ book will be carried out and the psychological problems of the participants will be measured twice, before and after the intervention to evaluate the results.

The most important contribution of the Project is conducting a feasibility study with the "Doing What Matters in Times of Stress: An Illustrated Guide" which will be adapted to the Turkish culture based on the determination of Turkey's current psychological status, provide a form of intervention to the Turkish psychological intervention literature and to improve the psychological status of the participants in this project.

Study Design

Study Type:
Interventional
Actual Enrollment :
126 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Feasibility Study of The Delivery of The Book From Self Help Plus: "Doing What Matters in Times of Stress: An Illustrated Guide"
Actual Study Start Date :
Nov 9, 2020
Actual Primary Completion Date :
Jan 29, 2021
Actual Study Completion Date :
Jan 29, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention Arm: Doing What Matters in Times of Stress: An Illustrated Guide

The intervention arm will receive the assigned intervention for five weeks. They will receive the intervention materials and will be called by psychologists three times (at the beginning, middle and end) during the intervention.

Behavioral: Doing What Matters in Times of Stress: An Illustrated Guide
The "Doing What Matters in Times of Stress: An Illustrated Guide" is a booklet that is developed by World Health Organization. It is a stress management booklet formed to provide people skills for coping with stress and adversity. The booklet has accompanying audio exercises.

No Intervention: Control Arm: Wait List

The control arm has no intervention. The participants in the control arm will receive the intervention after the post-assessments are completed.

Outcome Measures

Primary Outcome Measures

  1. Change of the Patient Health Questionnaire-9 (PHQ-9) over time [Change from baseline (1 week before the intervention) to post assessment (6 weeks after the pre-assessment)]

    Patient Health Questionnaire-9 is a 9 item questionnaire that aims to measure the severity of depression symptoms. Each of the 9 items are scored as "0" (not at all) to "3" (nearly every day), providing a 0-27 severity score. Higher scores indicate decreased functional status and increased symptom-related difficulties.

Secondary Outcome Measures

  1. Change of the General Anxiety Disorder-7 (GAD-7) over time [Change from baseline (1 week before the intervention) to post assessment (6 weeks after the pre-assessment)]

    General Anxiety Disorder-7 is a 7-item questionnaire that aims to measure anxiety symptoms. Each of the 7 items are scored as 0, 1, 2, and 3 to the response categories (0 = "not at all," to 3= "nearly every day"). The total score for the seven items ranges from 0 to 21. Higher scores indicate higher levels of anxiety.

  2. Change of the PTSD Checklist for The Diagnostic and Statistical Manual of Mental Disorders 5 (DSM 5) (PCL-5) over time [Change from baseline (1 week before the intervention) to post assessment 6 weeks after the pre-assessment)]

    The PTSD Checklist for DSM-5 is a 20-item questionnaire that assesses the symptoms of PTSD. In this study, a single question from each criteria of PTSD will be used. Overall four questions from PCL-5 will be assessed. Each of the 4 items are scored as 0, 1, 2, 3 and 4 (0 = "Not at all" to 4 = "Extremely"). The total score for the four items ranges from 0 to 16. Higher scores indicate higher levels of PTSD symptoms.

  3. Change of the The World Health Organization Quality of Life (WHOQOL) over time [Change from baseline (1 week before the intervention) to post assessment 6 weeks after the pre-assessment)]

    The World Health Organization Quality of Life questionnaire assesses various domains of life which are physical health, psychological health, social relationships, and environment. In this study, a single question from the questionnaire will be used which will be about the general quality of life. The question is scored from 1 to 5 on a response scale (1 = "Not at all" to 5 = "Completely"). A higher score indicate higher quality of life.

  4. Change of the The General Self-Efficacy Scale over time [Change from baseline (1 week before the intervention) to post assessment 6 weeks after the pre-assessment)]

    The General Self-Efficacy Scale is a 10-item questionnaire that assesses the general sense of perceived self-efficacy. Each of the 10 items are scored as 1, 2, 3 and 4 on a response scale (1 = "Not at all true" to 4 = "Exactly true"). The total score for the four items ranges from 10 to 40. Higher scores indicate higher perceived general self-efficacy, lower scores indicate lower perceived general self-efficacy.

  5. Change of the The Acceptance and Action Questionnaire (AAQ-2) over time [Change from baseline (1 week before the intervention) to post assessment 6 weeks after the pre-assessment)]

    The Acceptance and Action Questionnaire is a 7-item questionnaire that assesses the psychological flexibility. Each of the 7 items are scored as 1, 2, 3, 4, 5, 6 and 7 on a response scale (1 = "Never true" to 7 = "Always true"). The total score for the four items ranges from 7 to 49. Higher total scores mean less flexibility, while lower total scores mean more flexibility.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Being 18 years or above

  • Being literate

  • Being a Turkish citizen or a Syrian refugee

  • Scoring 15 or above on Kessler Psychological Distress Scale (K10)

Exclusion Criteria:
  • Imminent suicidal risk

  • Being illiterate

Contacts and Locations

Locations

Site City State Country Postal Code
1 Koc University Istanbul Turkey

Sponsors and Collaborators

  • Koç University

Investigators

  • Study Chair: Gülşah Kurt, PhD, Koç University
  • Study Chair: Zeynep Ilkkursun, MA, Koç University

Study Documents (Full-Text)

More Information

Publications

Responsible Party:
Ceren Acarturk, Associate Professor, Koç University
ClinicalTrials.gov Identifier:
NCT04631887
Other Study ID Numbers:
  • 2020.200.IRB3.080
First Posted:
Nov 17, 2020
Last Update Posted:
Feb 21, 2021
Last Verified:
Feb 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 21, 2021